ChiCTR2100048440
Untitled Trial
397 day surveillance of multi omic molecular resources for COVID 19 patients
Taizhou Hospital of Zhejiang Province·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Taizhou Hospital of Zhejiang Province
- Funder
- National Key R&D Program of China (No. 2020YFE0202200), National Natural Science Foundation of China (81972492, 21904107, 81672086, 82072333) et al.
- Location
- China
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- Feb 25, 2022
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100048440
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100048440 through Pure Global AI's free database. This phase not specified trial is sponsored by Taizhou Hospital of Zhejiang Province and is currently Recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.